The Jenner Institute
  • About Us
    • About the Jenner Institute
    • Jenner Vaccine Foundation
    • Scientific Advisory Board
    • Funders & Partners
    • About Edward Jenner
  • Investigators & Staff
    • Contacts & Directory
    • Organisational Structure
    • Jenner Investigators
    • Post-doctoral Researchers
    • Clinical Research Fellows
  • Research Programmes
    • Avian and Swine Flu
    • Bovine Tuberculosis
    • Foot and Mouth Disease
    • Genetic Susceptibility to Infection
    • Grand Challenges for Global Health
    • HIV
    • Hepatitis C
    • Human Influenza
    • Human Tuberculosis
    • Malaria
    • Meningitis
    • Other Livestock Diseases
    • Oxford Martin Vaccine Design Programme
    • Staphylococcus Aureus
    • Vaccine Delivery Technology
    • Vector Engineering
  • Graduate Studies
    • Graduate Applications
    • Funding & Scholarships
    • Internships
    • Meet our Staff & Students
  • Core Facilities
    • Overview of Core Facilities
    • Adjuvant Bank Facility
    • Flowcytometry Facility
    • Viral Vector Core Facility
  • Locations
    • Jenner Institute Laboratories
    • Institute for Animal Health
    • Centre for Clinical Vaccinology and Tropical Medicine
    • Wellcome Trust Centre for Human Genetics
    • Clinical Biomanufacturing Facility
  • Vacancies
    • Job Applications
    • Vacancies
    • Working at the Jenner Institute
    • Meet our Staff & Students
  • Intranet

The Jenner Institute

is a research partnership between the University of Oxford and the Institute for Animal Health

The Institute focuses on the parallel development of human and veterinary vaccines against major global diseases - from early-stage research through to clinical trials.


Funding Opportunities. Visit the Jenner Vaccine Foundation for more information.


Virtual Tour of the Jenner Labs

Media

Media contacts

News & media coverage

Homepage

Team of collaborators from UK, South Africa, Senegal and The Gambia in Phase IIb efficacy trial of TB vaccine 'MVA85A' in HIV-infected adults in South Africa and Senegal

Vaccines for phase IIa trials in Oxford are manufactured at the University's Clinical Biomanufacturing Facility /JI/investigators Old Road Campus Research Building - the Institute's administrative headquarters and main human vaccines laboratories /JI/locations Buffalo inoculation - part of Foot-and-Mouth Vaccine Programme led by Jenner Investigator, Dr Bryan Charleston, Institute for Animal Health /JI/applicationprocessother Architectural image of new Institute for Animal Health laboratories currently under contruction in Pirbright, UK /JI/prof-adrian-hill Team of collaborators from UK, South Africa, Senegal and The Gambia in Phase IIb efficacy trial of TB vaccine 'MVA85A' in HIV-infected adults in South Africa and Senegal /JI/currvac

<< 1 2 3 4 5 >>

News

Initial tests in animals shows an experimental malaria vaccine to halt many strains, based on key findings on how parasite enters blood cells. The research team hopes to start first human trials in 2 to 3 years.

Clinical Trials

Volunteers are needed to help in testing of vaccines developed in Oxford against Malaria, Tuberculosis, HIV, Hepatitis C and Influenza. The trials take place at the Churchill Hospital, Oxford.

 

Training in Vaccinology

The Oxford Vaccinology Programme offers a 5-day Human and Veterinary Vaccinology course and 2-day courses in Clinical Vaccine Development and Vaccine Biomanufacturing.

 

Events & Seminars

Jenner Seminars are held monthly and feature lead researchers in human or veterinary vaccinology. The seminars are open to all.

ndm

Contact Us

Staff Directory

 
New Vaccines for Global Health - free online access until end 2011

Resources & Outreach

Podcasts & videoclips

Events & seminars

Working at the Jenner Institute

Meet our staff and students

What are vaccines?

About Malaria

Bookmark this page Share Print page